Related Experiment Video
Updated: Jul 20, 2026

Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model
Published on: April 7, 2023
Mifepristone vaginally in an early medical abortion regimen: a pilot study
Sunita Sharma1, Hazem El-Refaey, Helen Mitchel
1Department of Obstetrics and Gynecology, Chelsea and Westminster Hospital, London SW10 9NH, UK.
Objective:
This prospective observational pilot study was undertaken to assess the efficacy of mifepristone and misoprostol, both administered vaginally. The ultimate goal is to investigate alternative means of reducing the time interval between the two treatments involved. The efficacy of the early medical abortion regimen utilizing mifepristone and misoprostol is beyond doubt. The regimen usually involves administering misoprostol 36 h following oral administration of mifepristone. The interval between the two treatment components might affect a woman's choice of the medical method.
Methods:
Eighteen women undergoing abortion for nonmedical reasons were recruited.
Results:
Seven women required further intervention to achieve complete abortion. Median induction-to-abortion interval was 7.66 h in the 11 women with complete abortion.
Conclusion:
The complete abortion rate of 61% in this study was lower than that with the standard medical regimen.
Related Concept Videos
In Vitro Fertilization
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
Intrauterine Drug Delivery Systems

